{
  "id": "5e543704b761aafe09000001",
  "type": "summary",
  "question": "What is MLE4901?",
  "ideal_answer": "MLE4901 is an oral neurikinin 3 receptor antagonist that has been shown to safely and effectively relieve hot flush symptoms in menopausal women without the need for oestrogen exposure.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28385352"
  ],
  "snippets": [
    {
      "text": "This phase 2, randomised, double-blind, placebo-controlled, single-centre, crossover trial assessed the effectiveness of an oral neurokinin 3 receptor antagonist (MLE4901) on menopausal hot flushes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28385352",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Treatment with a neurokinin 3 receptor antagonist (MLE4901) could be practice changing as it safely and effectively relieves hot flush symptoms without the need for oestrogen exposure. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28385352",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}